Active Ingredient History
Inosine pranobex is an antiviral drug that is a combination of inosine and dimepranol acedoben in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Amyotrophic Lateral Sclerosis (Phase 2)
Cholestasis, Intrahepatic (Phase 2/Phase 3)
Cognitive Dysfunction (Phase 3)
COVID-19 (Phase 3)
Diabetic Neuropathies (Phase 3)
Head Injuries, Closed (Phase 3)
Healthy Volunteers (Phase 1)
Heart Transplantation (Early Phase 1)
HIV Infections (Phase 4)
Jaundice, Obstructive (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Multiple System Atrophy (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2/Phase 3)
Parkinson Disease (Phase 3)
Pneumonia (Phase 1)
Respiratory Tract Infections (Phase 3)
Stroke (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue